NCT00880334 Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC Status COMPLETED Phase PHASE2
NCT00870675 Magnetic Resonance Imaging (MRI) of Ventriculomegaly: Morphology and Outcome Status COMPLETED Phase N/A
NCT00869999 Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00866723 Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer Status TERMINATED Phase PHASE2
NCT00859222 LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT00842257 Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00833547 Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia Status COMPLETED Phase NA
NCT00828685 Early Functional Outcomes After Closed Reduction With Pinning Versus Open Reduction Internal Fixation of Wrist Fractures Status COMPLETED Phase NA
NCT00827359 Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00819546 RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00813293 Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer Status COMPLETED Phase PHASE2
NCT00808639 Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT00804336 Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors Status COMPLETED Phase PHASE1
NCT00801320 Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer Status COMPLETED Phase NA